Table 2. .

Study Population Demographics

Patient	Sex	Age, y	Diagnosis	Additional Medications
HSV/HZO Keratitis
1	M	66	HZO keratitis	1, 7
2	F	80	HZO keratitis	2, 3
3	F	72	HSV keratitis	1, 4
4	M	35	HSV keratitis, corneal ulcer	1, 2, 7
5	M	24	HSV keratitis	1, 2, 3, 7
6	F	71	HSV keratitis	None
7	F	74	HZO keratitis, bacterial ulcer	1, 2, 5
Keratoplasty/Failed Graft
8	M	59	Aphakic bullous keratopathy, PKP	2, 5
9	F	66	Traumatic cataract, PBK	1, 2, 3, 5, 7
10	M	41	Fungal keratitis, PKP	3, 6
11	M	41	Microbial ulcer, PKP	3, 7
12	M	38	Microphthalmia, sclero-cornea	5
13	F	56	Corneal perforation, keratoconus	1
Limbal Stem Cell Deficiency
14	M	79	Limbal stem cell deficiency	1, 2, 5, 6
Pterygium
15	M	77	MGD, rosacea, DES, recurrent pterygium	1
Trauma
16	M	44	Trauma, corneal scarring	1
17	M	68	Traumatic corneal perforation	5
18	M	35	SLK	1
19	M	29	Stevens-Johnson syndrome	1, 3
20	M	27	Rosacea, chronic blepharitis	2

HZO, herpes zoster ophthalmicus; HSV, herpes simplex virus; PKP, penetrating keratoplasty; PBK, Pseudophakic bullous keratopathy; MGD, meibomian gland dysfunction; DES, dry eye syndrome; SLK, superior limbic keratoconjunctivitis; 1, Artificial tears; 2, Topical steroid; 3, Topical antibiotic; 4, Oral antiviral; 5, Topical antiglaucoma; 6, Topical cyclosporine; 7, Oral antibiotics.